Skip to main content

Table 1 Clinical characteristics for men presenting for evaluation and treatment of adult onset hypogonadism, and men treated chronically with transdermal testosterone

From: SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking?

 

Adult onset hypogonadism

(n = 33)

T-treated hypogonadal men

(n = 25)

P value

Age (yrs)

45 (31.5–55.0)a

61.0 (48.0–67.5)

.002

BMI (kg/m2)

32.0 (27.8–39.3)

29.1 (24.6–33.1)

.04

Testosterone (ng/dL)

317 (237–391)

452 (360–528)

.001

SHBG (nmol/L)

25.7 (21.2–35.0)

31.0 (22.5–40.5)

.189

Free testosterone (pg/mL)

50.7 (44.5–61.5)

65.3 (45.8–95.0)

.084

  1. To convert total testosterone levels to nmol/L multiply by 0.0347
  2. aMedian (25–75%)